Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention

Table 4

Clinical outcomes during 1-year follow-up in the propensity score-matched population.

propensity score-matched population	Clopidogrel; (n=240)	Ticagrelor; (n=240)	Adjusted HR(95%CI)	P value
Primary end point
Cardiac death, MI, or Stroke	32(13.33)	17(7.08)	0.403(0.217-0.749)	0.004
Secondary end point
Cardiac death	6(2.50)	5(2.08)	0.577(0.157-2.118)	0.407
MI	22(9.17)	9(3.75)	0.306(0.135-0.696)	0.005
Stroke	6(2.50)	3(1.25)	0.334(0.073-1.535)	0.159
Stent thrombosis	9(3.75)	5(2.08)	0.384(0.152-1.541)	0.219
Bleeding
All BARC type Bleeding	38(15.83)	60(25.00)	1.833(1.212-2.773)	0.004
Major bleeding	5(2.08)	6(2.50)	0.712(0.189-2.674)	0.614

Results are expressed as n (%).
For abbreviation definitions, please see the legend in Table 3.